24.36
price up icon5.00%   1.16
 
loading
Schlusskurs vom Vortag:
$23.20
Offen:
$23.39
24-Stunden-Volumen:
3.08M
Relative Volume:
1.15
Marktkapitalisierung:
$2.10B
Einnahmen:
$19.32M
Nettoeinkommen (Verlust:
$-141.47M
KGV:
-14.46
EPS:
-1.6851
Netto-Cashflow:
$-120.48M
1W Leistung:
+8.85%
1M Leistung:
+7.12%
6M Leistung:
+74.37%
1J Leistung:
+124.52%
1-Tages-Spanne:
Value
$23.04
$24.71
1-Wochen-Bereich:
Value
$22.05
$24.71
52-Wochen-Spanne:
Value
$9.71
$29.94

Liquidia Corp Stock (LQDA) Company Profile

Name
Firmenname
Liquidia Corp
Name
Telefon
919.328.4400
Name
Adresse
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Name
Mitarbeiter
170
Name
Twitter
@Liquidia_Inc
Name
Nächster Verdiensttermin
2025-03-19
Name
Neueste SEC-Einreichungen
Name
LQDA's Discussions on Twitter

Vergleichen Sie LQDA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
LQDA
Liquidia Corp
24.36 2.00B 19.32M -141.47M -120.48M -1.6851
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.04 58.93B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.60 41.29B 398.11M -1.03B -868.57M -5.7032

Liquidia Corp Stock (LQDA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-20 Eingeleitet Wells Fargo Overweight
2025-08-15 Fortgesetzt Jefferies Buy
2025-05-19 Herabstufung Oppenheimer Perform → Underperform
2024-12-20 Eingeleitet Wells Fargo Overweight
2024-10-16 Eingeleitet Scotiabank Sector Outperform
2024-08-19 Hochstufung Raymond James Outperform → Strong Buy
2024-08-16 Eingeleitet Raymond James Outperform
2024-06-25 Eingeleitet Oppenheimer Perform
2024-01-05 Bestätigt Needham Buy
2022-09-19 Fortgesetzt Wedbush Underperform
2022-09-01 Herabstufung Wedbush Neutral → Underperform
2022-07-22 Eingeleitet Ladenburg Thalmann Buy
2022-05-31 Eingeleitet BTIG Research Buy
2022-05-26 Eingeleitet BofA Securities Buy
2020-12-04 Eingeleitet H.C. Wainwright Buy
2020-11-20 Herabstufung Wedbush Outperform → Neutral
2018-11-08 Fortgesetzt Jefferies Buy
2018-09-05 Eingeleitet Wedbush Outperform
2018-08-20 Eingeleitet Jefferies Buy
2018-08-20 Eingeleitet Needham Buy
Alle ansehen

Liquidia Corp Aktie (LQDA) Neueste Nachrichten

pulisher
Oct 31, 2025

Liquidia Corp (LQDA) Q3 2025 Earnings Report Preview: What To Ex - GuruFocus

Oct 31, 2025
pulisher
Oct 31, 2025

Will Liquidia Corporation (LT4) stock outperform small cap peersMarket Sentiment Review & Long-Term Capital Growth Strategies - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How Liquidia Corporation stock performs in stagflationQuarterly Portfolio Review & Weekly Hot Stock Watchlists - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Liquidia Corporation showing signs of accumulationEarnings Overview Report & Fast Momentum Stock Entry Tips - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Does Liquidia Corporation show high probability of reboundTrade Analysis Report & Daily Volume Surge Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Will Liquidia Corporation (LT4) stock profit from automation waveTrade Volume Report & Real-Time Stock Price Movement Reports - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Liquidia (NASDAQ:LQDA) CAO Dana Boyle Sells 1,073 Shares - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Insider Selling: Liquidia (NASDAQ:LQDA) Insider Sells 692 Shares of Stock - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Liquidia CorpUnit enters exclusive licensing agreement with VecturaSEC filing - MarketScreener

Oct 30, 2025
pulisher
Oct 30, 2025

Has Liquidia Corporation formed a bullish divergence2025 Market Sentiment & Real-Time Stock Price Movement Reports - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Will Liquidia Corporation (LT4) stock sustain uptrend momentumInsider Buying & Safe Capital Allocation Plans - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

What dividend safety rating applies to Liquidia Corporation (LT4) stockShort Setup & Low Drawdown Momentum Ideas - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Liquidia (LQDA) Expected to Announce Earnings on Monday - MarketBeat

Oct 29, 2025
pulisher
Oct 28, 2025

What sentiment indicators say about Liquidia Corporation stockEarnings Overview Summary & Stock Portfolio Risk Management - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

Will Liquidia Corporation stock keep outperforming rivals2025 Price Targets & Safe Entry Zone Tips - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Will Liquidia Corporation stock attract more institutional investorsBuy Signal & Accurate Entry/Exit Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025 - Quiver Quantitative

Oct 27, 2025
pulisher
Oct 27, 2025

Liquidia (NASDAQ: LQDA) sets Nov. webcast at 8:30 a.m. ET to discuss Q3 results - Stock Titan

Oct 27, 2025
pulisher
Oct 26, 2025

Liquidia's (LQDA) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 26, 2025
pulisher
Oct 23, 2025

Applying sector rotation models to Liquidia CorporationQuarterly Portfolio Review & Advanced Swing Trade Entry Plans - newser.com

Oct 23, 2025
pulisher
Oct 21, 2025

Wall Street Analysts Believe LIQUIDIA CORP (LQDA) Could Rally 50.94%: Here's is How to Trade - sharewise.com

Oct 21, 2025
pulisher
Oct 21, 2025

Liquidia Corporation (LQDA) Stock Analysis: Exploring a 50.94% Potential Upside in a Booming Biotechnology Sector - DirectorsTalk Interviews

Oct 21, 2025
pulisher
Oct 21, 2025

Liquidia Corp: Shares Remain Mispriced Despite Yutrepia's Exceptional Commercial Launch - Seeking Alpha

Oct 21, 2025

Finanzdaten der Liquidia Corp-Aktie (LQDA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Liquidia Corp-Aktie (LQDA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Boyle Dana
Chief Accounting Officer
Oct 27 '25
Sale
22.93
1,073
24,604
184,338
Schundler Russell
General Counsel
Oct 13 '25
Sale
23.41
7,839
183,511
576,017
Kaseta Michael
CFO and COO
Oct 13 '25
Sale
23.41
11,630
272,258
352,646
Moomaw Scott
Chief Commercial Officer
Oct 13 '25
Sale
23.41
4,900
114,709
153,462
Saggar Rajeev
Chief Medical Officer
Oct 13 '25
Sale
23.41
5,327
124,705
247,930
Boyle Dana
Chief Accounting Officer
Oct 13 '25
Sale
23.41
1,238
28,982
185,411
JEFFS ROGER
Chief Executive Officer
Oct 13 '25
Sale
23.41
20,261
474,310
1,032,973
Adair Jason
Chief Business Officer
Oct 13 '25
Sale
23.41
3,670
85,915
175,690
Krepp Sarah
Chief Human Resource Officer
Oct 13 '25
Sale
23.41
1,691
39,586
141,439
SINGH RAMAN
Director
Sep 15 '25
Option Exercise
2.55
45,524
115,865
76,779
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
Kapitalisierung:     |  Volumen (24h):